Sickle cell raises COVID-19 risk, but vaccination lags
Adults with sickle cell disease around half as likely to have gotten initial doses as people without sickle cell disease, according to new research from University of Michigan researchers.
Vaccines
The pandemic's role in shaping parents' attitudes toward vaccines
Q&A with Abram L. Wagner
A recent study conducted by Michigan Public Health researchers examines the impact of the COVID-19 pandemic on parental vaccine hesitancy.
Why COVID vaccines for young children have been hard to get
Brian Zikmund-Fisher quoted in Scientific American
Brian Zikmund-Fisher, professor of Health Behavior and Health Education, highlights the importance of public health messaging related to boosting COVID-19 vaccination rates in children.
New COVID-19 vaccine a good value for US, University of Michigan team finds
Economic model created for CDC shows that in older adults promoting updated vaccination will save the US money, while in other adults it should be reasonably cost effective.
Weiser Professional Development Fellow visits Michigan Public Health, reconnects with longtime collaborator
Bosiljka Djikanovic visited as part of Ronald and Eileen Weiser Center for Europe and Eurasia program
Earlier this year, Serbian professor and public health researcher Bosiljka Djikanovic visited the University of Michigan School of Public Health as part of a faculty development program hosted by the Weiser Center for Europe and Eurasia.
FDA expert panel endorses idea of removing a component from flu vaccine
Arnold Monto quoted in Stat
The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline.